This series on “Changes in Management of Mediastinal Tumours Following the Surge of COVID-19 Pandemic” is edited by Dr. Giuseppe Banna, MD, Department of Medical Oncology, Portsmouth Hospitals NHS Trust, Portsmouth, UK and Dr. Alfredo Addeo, MD, Oncology Department, University Hospital Geneva, Geneva, Switzerland.
Editorial
The clinical fallout of organizational resilience in oncology during the pandemic
Review Article
Surgery for recurrent thymoma during the COVID-19 pandemic: a narrative review
Systemic treatments for thymic tumors: a narrative review
Targeted therapies for unresectable stage III non-small cell lung cancer
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic
The use of aerosol generating procedures (AGPs) during the COVID-19 pandemic in the diagnosis of lung cancer: a narrative review
A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer
Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative review
Disclosure:
The series “Changes in Management of Mediastinal Tumours Following the Surge of COVID-19 Pandemic” was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Drs Giuseppe Banna and Alfredo Addeo are serving as the unpaid Guest Editor for the series.
